Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Expected 12-week outcome without AOD-9604: approximately 5-6 kg total weight loss, roughly 3.5-4 kg from fat, 1-2 kg from lean tissue and water
Canadian Healthcare Considerations Access to sleep studies and CPAP equipment varies across Canadian provinces
(2022) Tirzepatide - a dual GIP/GLP-1 receptor agonist - a new antidiabetic drug with potential metabolic activity in the treatment of type 2 diabetes
Consult your prescribing doctor
Over time, it slows down the speed at which food leaves your stomach, causing you to feel full sooner and longer
US$ 22.20
US$ 24.26
US$ 26.79
US$ 23.32
US$ 24.77
US$ 20.70
US$ 22.17
